Atinvicitinib Patent Expiration
About Veterinary Atinvicitinib
Atinvicitinib is used in a drug marketed by 1 company: Intervet Inc.
Other drugs containing Atinvicitinib are: Numelvi .
Veterinary Atinvicitinib Patents
Given below is the list of patents protecting Atinvicitinib, along with the drug name that holds that patent and the company owning that drug.
| Drug Used In | Drug Patent Number | Drug Patent Expiry | Drug Owner |
|---|---|---|---|
 | |||
| Numelvi | US10875847 | 13 Dec, 2037 | INTERVET, INC. |
| Numelvi | US9394282 | 03 Jan, 2033 | INTERVET, INC. |
Atinvicitinib's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List